NeuroPace beats Q1 2026 EPS and revenue estimates and raises 2026 revenue guidance to $99–$101 million
- Fiscal Q1 2026 non-GAAP EPS was $-0.20, improving 5% year over year.
- Q1 2026 revenue was $22.0M, a 2% decline compared with the prior-year period.
- GAAP net loss for Q1 2026 was $0.20 per share.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.